Bio-Tissue Announces Strategic Agreement with Optima Pharmazeutische GmbH to Distribute its Natural Ocular Cleanser in Germany
MIAMI & MUNICH/HALLBERGMOOS, Germany--(BUSINESS WIRE)--Bio-Tissue, Inc., a business unit of TissueTech, Inc., is pleased to announce a strategic agreement with Optima Pharmazeutische GmbH, a leading distributor of ophthalmic products for the treatment of dry eye, blepharitis and meibomian gland dysfunction (MGD) in Germany and Austria. The agreement supports efforts to bring Bio-Tissue’s natural ocular cleanser formulated with 4-Terpineol, Cliradex®, to the German eye care professionals market.